The DOI matches its OpenAlex record.
Efficacy of screening mammography. A meta-analysis
Abstract
OBJECTIVE: To determine the efficacy of screening mammography by age, number of mammographic views per screen, screening interval, and duration of follow-up. DESIGN: Literature review and meta-analysis. DATA IDENTIFICATION AND ANALYSIS: Literature search of English-language studies reported from January 1966 to October 31, 1993, using MEDLINE, manual literature review, and consultation with experts. A total of 13 studies were selected, and their results were combined using meta-analytic techniques based on the assumption of fixed effects. MAIN RESULTS: The overall summary relative risk (RR) estimate for breast cancer mortality for women aged 50 to 74 years undergoing screening mammography compared with those who did not was 0.74 (95% confidence interval [CI], 0.66 to 0.83). The magnitude of the benefit in this age group was similar regardless of number of mammographic views per screen, screening interval, or duration of follow-up. In contrast, none of the summary RR estimates for women aged 40 to 49 years was significantly less than 1.0, irrespective of screening intervention or duration of follow-up. The overall summary RR estimate in women aged 40 to 49 years was 0.93 (95% CI, 0.76 to 1.13); the summary RR estimate for those studies that used two-view mammography was 0.87 (95% CI, 0.68 to 1.12) compared with 1.02 (95% CI, 0.73 to 1.44) for those studies that used one-view mammography, and for those studies with 7 to 9 years of follow-up, the summary RR estimate was 1.02 (95% CI, 0.82 to 1.27) compared with 0.83 (95% CI, 0.65 to 1.06) for those studies with 10 to 12 years of follow-up. CONCLUSION: Screening mammography significantly reduces breast cancer mortality in women aged 50 to 74 years after 7 to 9 years of follow-up, regardless of screening interval or number of mammographic views per screen. There is no reduction in breast cancer mortality in women aged 40 to 49 years after 7 to 9 years of follow-up. Screening mammography may be effective in reducing breast cancer mortality in women aged 40 to 49 years after 10 to 12 years of follow-up, but the same benefit could probably be achieved by beginning screening at menopause or 50 years of age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
Concato, J., Shah, N., & Horwitz, R. I. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422507 · Cited by 3,563
Systematic Reviews: Synthesis of Best Evidence for Clinical Decisions
Cook, D. J., Mulrow, C. D., & Haynes, R. B. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-5-199703010-00006 · Cited by 2,184
Screening for breast cancer with mammography
Gøtzsche, P. C., & Jørgensen, K. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001877.pub5 · Cited by 1,869
Kolb, T. M., Lichy, J., & Newhouse, J. H. (2002) · Radiology · doi:10.1148/radiol.2251011667 · Cited by 1,718
Breast Cancer Screening: A Summary of the Evidence for the U.S. Preventive Services Task Force
Humphrey, L. L., Helfand, M., Chan, B. K. S., & Woolf, S. H. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-5_part_1-200209030-00012 · Cited by 1,137
Cancer Screening in Elderly Patients: A Framework for Individualized Decision Making
Walter, L. C., & Covinsky, K. E. (2001) · JAMA · doi:10.1001/jama.285.21.2750 · Cited by 1,003
Burke, W. (1997) · JAMA · doi:10.1001/jama.277.12.997 · Cited by 955
Comparison of Evidence of Treatment Effects in Randomized and Nonrandomized Studies
Ioannidis, J. P. A. (2001) · JAMA · doi:10.1001/jama.286.7.821 · Cited by 919
Polygenic susceptibility to breast cancer and implications for prevention
Pharoah, P. D. P., Antoniou, A., Bobrow, M., Zimmern, R. L., Easton, D. F., & Ponder, B. A. J. (2002) · Nature Genetics · doi:10.1038/ng853 · Cited by 899
Weir, H. K. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg040 · Cited by 867
Is screening for breast cancer with mammography justifiable?
Gøtzsche, P. C., & Olsen, O. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06065-1 · Cited by 853
Lee, C. H., Dershaw, D. D., Kopans, D., Evans, P., Monsees, B., Monticciolo, D., Brenner, R. J., Bassett, L., Berg, W., Feig, S., et al. (2010) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2009.09.022 · Cited by 809
Hortobagyi, G. N. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810013391407 · Cited by 781
Machine learning and radiology
Wang, S., & Summers, R. M. (2012) · Medical Image Analysis · doi:10.1016/j.media.2012.02.005 · Cited by 697
Tumor Characteristics and Clinical Outcome of Elderly Women With Breast Cancer
Diab, S. G. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.7.550 · Cited by 674
Communicating Statistical Information
Hoffrage, U., Lindsey, S., Hertwig, R., & Gigerenzer, G. (2000) · Science · doi:10.1126/science.290.5500.2261 · Cited by 651
Incidence of and Treatment for Ductal Carcinoma In Situ of the Breast
Ernster, V. L. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530360023033 · Cited by 626
Kuhl, C. K., Schmutzler, R. K., Leutner, C. C., Kempe, A., Wardelmann, E., Hocke, A., Maringa, M., Pfeifer, U., Krebs, D., & Schild, H. H. (2000) · Radiology · doi:10.1148/radiology.215.1.r00ap01267 · Cited by 538
Clegg, L. X., Li, F. P., Hankey, B. F., Chu, K., & Edwards, B. K. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.17.1985 · Cited by 535
(1999) · National Academies Press eBooks · doi:10.17226/6467 · Cited by 526
Miller, A. B. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1490 · Cited by 512
Warner, E. (2011) · New England Journal of Medicine · doi:10.1056/nejmcp1101540 · Cited by 504
Moss, S. M., Cuckle, H., Evans, A., Johns, L., Waller, M., & Bobrow, L. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69834-6 · Cited by 503
Planning cancer control in Latin America and the Caribbean
Goss, P. E., Lee, B. L., Badovinac-Crnjevic, T., Strasser-Weippl, K., Chavarri-Guerra, Y., Louis, J. S., Villarreal-Garza, C., Unger-Saldaña, K., Ferreyra, M., Debiasi, M., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70048-2 · Cited by 499
Warner, E., Plewes, D. B., Shumak, R. S., Catzavelos, G. C., Di Prospero, L. S., Yaffe, M. J., Goel, V., Ramsay, E., Chart, P. L., Cole, D. E. C., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.15.3524 · Cited by 461
Randomisation to protect against selection bias in healthcare trials
Odgaard-Jensen, J., Vist, G. E., Timmer, A., Kunz, R., Akl, E. A., Schünemann, H., Briel, M., Nordmann, A. J., Pregno, S., & Oxman, A. D. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000012.pub3 · Cited by 439
Schrag, D., Kuntz, K. M., Garber, J. E., & Weeks, J. C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362022 · Cited by 435
Wright, J., Johns, R., Watt, I., Melville, A., & Sheldon, T. (1997) · BMJ · doi:10.1136/bmj.314.7084.851 · Cited by 414
The Promise and Problems of Meta-Analysis
Bailar, J. C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708213370810 · Cited by 402
14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening
Alexander, F., Anderson, T., Brown, H., Forrest, A., Hepburn, W., Kirkpatrick, A., Muir, B., Prescott, R., & Smith, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07413-3 · Cited by 388
Prognostic value of proliferation in invasive breast cancer: a review: Table 1
van Diest, P. J., van der Wall, E., & Baak, J. P. A. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.010777 · Cited by 385
From Wearable Sensors to Smart Implants-–Toward Pervasive and Personalized Healthcare
Andreu-Perez, J., Leff, D. R., Ip, H. M. D., & Yang, G.-Z. (2015) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2015.2422751 · Cited by 383
Barton, M. B., Harris, R., & Fletcher, S. W. (1999) · JAMA · doi:10.1001/jama.282.13.1270 · Cited by 375
Streckfus, C., & Bigler, L. (2002) · Oral Diseases · doi:10.1034/j.1601-0825.2002.1o834.x · Cited by 374
“For example, an inexpensive saliva test used in conjunction with imaging (e.g. mammography) may increase the overall diagnostic value of the latter test and reduce the number of false positives and negatives currently associated with imaging (Kerlikowske et al, 1995).”
Fear, Anxiety, Worry, and Breast Cancer Screening Behavior: A Critical Review
Consedine, N. S., Magai, C., Krivoshekova, Y. S., Ryzewicz, L., & Neugut, A. I. (2004) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.501.13.4 · Cited by 370
Newman, B. (1998) · JAMA · doi:10.1001/jama.279.12.915 · Cited by 345
Implementation of Breast Tomosynthesis in a Routine Screening Practice: An Observational Study
Rose, S. L., Tidwell, A. L., Bujnoch, L. J., Kushwaha, A. C., Nordmann, A. S., & Sexton, R. (2013) · American Journal of Roentgenology · doi:10.2214/ajr.12.9672 · Cited by 329
The psychological impact of mammographic screening. A systematic review
Brett, J., Bankhead, C., Henderson, B., Watson, E., & Austoker, J. (2005) · Psycho-Oncology · doi:10.1002/pon.904 · Cited by 327
Assessing the Risk of Breast Cancer
Armstrong, K., Eisen, A., & Weber, B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002243420807 · Cited by 317
Screening for breast cancer with mammography
Gøtzsche, P. C., & Nielsen, M. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001877.pub4 · Cited by 311
Brekelmans, C. T. M., Seynaeve, C., Bartels, C. C. M., Tilanus-Linthorst, M. M. A., Meijers-Heijboer, E. J., Crepin, C. M. G., van Geel, A. N., Menke, M., Verhoog, L. C., van den Ouweland, A., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.924 · Cited by 307
Selvin, E., & Brett, K. M. (2003) · American Journal of Public Health · doi:10.2105/ajph.93.4.618 · Cited by 304
Ohayon, M. M., Guilleminault, C., Priest, R. G., & Caulet, M. (1997) · BMJ · doi:10.1136/bmj.314.7084.860 · Cited by 303
Screening for Cervical and Breast Cancer: Is Obesity an Unrecognized Barrier to Preventive Care?
Wee, C. C., McCarthy, E. P., Davis, R. B., & Phillips, R. S. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-9-200005020-00003 · Cited by 298
Magnetic Resonance Imaging and Mammography in Women With a Hereditary Risk of Breast Cancer
Stoutjesdijk, M. J., Boetes, C., Jager, G. J., Beex, L., Bult, P., Hendriks, J. H. C. L., Laheij, R. J. F., Massuger, L., van Die, L. E., Wobbes, T., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1095 · Cited by 289
Re: Magnetic Resonance Imaging and Mammography in Women With a Hereditary Risk of Breast Cancer
Goffin, J., Chappuis, P. O., Wong, N., & Foulkes, W. D. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.22.1754 · Cited by 284
Schwartz, L. M. (2000) · BMJ · doi:10.1136/bmj.320.7250.1635 · Cited by 264
Screening for breast cancer with mammography
Gøtzsche, P. C., & Nielsen, M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001877.pub2 · Cited by 260
Baillet, A., Gossec, L., Carmona, L., Wit, M. D., van Eijk-Hustings, Y., Bertheussen, H., Alison, K., Toft, M., Kouloumas, M., Ferreira, R. J. O., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209233 · Cited by 259
Inequalities in breast and cervical cancer screening among urban Mexican women
Couture, M.-C., Nguyen, C. T., Alvarado, B. E., Velasquez, L. D., & Zunzunegui, M.-V. (2008) · Preventive Medicine · doi:10.1016/j.ypmed.2008.07.005 · Cited by 255
Cancer and ageing: a nexus at several levels
Balducci, L., & Ershler, W. B. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1675 · Cited by 250
The impact of diabetes on survival following breast cancer
Lipscombe, L. L., Goodwin, P. J., Zinman, B., McLaughlin, J. R., & Hux, J. E. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9654-0 · Cited by 176
Mitchell, A. J., & Lord, O. (2010) · Journal of Psychopharmacology · doi:10.1177/1359786810382056 · Cited by 108
Greenwood, N. W., Dreyfus, D., & Wilkinson, J. (2014) · Intellectual and Developmental Disabilities · doi:10.1352/1934-9556-52.6.444 · Cited by 35
Lee, J. T., Huang, Z., Basu, S., & Millett, C. (2015) · Journal of Epidemiology and Community Health · doi:10.1136/jech-2014-204355 · Cited by 27
Delays in Follow-up Care for Abnormal Mammograms in Mobile Mammography Versus Fixed-Clinic Patients
Vang, S. S., Dunn, A., Margolies, L. R., & Jandorf, L. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-021-07189-3 · Cited by 14
Metadata
- Authors
- Kerlikowske, K. M.
- Venue
- JAMA
- Publisher
- American Medical Association
- Published
- 1995-01-11
- Volume
- 273
- Issue
- 2
- Pages
- 149-154
- ISSN
- 0002-9955 (ISSN-L)
- OpenAlex
- W4236953343
- Cited by
- 1,131
- References
- 0
- FWCI
- 22.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.